Cutaneous lupus erythematosus - from pathogenesis to targeted therapy

Area of Science:

• Dermatology
• Immunology
• Pathogenesis of skin diseases

Background:

• Cutaneous lupus erythematosus (CLE) is a complex inflammatory skin disease.
• CLE presents alone or with systemic lupus erythematosus (SLE).
• CLE subtypes exhibit clinical heterogeneity and varied SLE associations.

Purpose of the Study:

• To explore the pathogenesis of cutaneous lupus erythematosus.
• To understand the role of immune cells and cytokines in CLE.
• To identify targets for novel therapies and prevention strategies.

Main Methods:

• Histological analysis of skin biopsies.
• Characterization of non-lesional and lesional lupus skin.
• Investigation of immune cell infiltration and cytokine profiles.

Main Results:

• CLE is characterized by interface dermatitis with immune-cell infiltration.
• Upregulation of type I interferons in lupus skin drives key pathogenic features.
• Type I interferons contribute to photosensitivity and myeloid-cell recruitment.

Conclusions:

• Detailed understanding of CLE biology has facilitated targeted therapy development.
• Ongoing research into pathogenic mechanisms offers opportunities for CLE prevention.
• Future research may prevent CLE and the transition from CLE to SLE.